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Vesicle miR-195 derived from 
Endothelial Cells Inhibits 
Expression of Serotonin Transporter 
in Vessel Smooth Muscle Cells
Junzhong Gu1, Huiyuan Zhang1, Bingyang Ji2, Hui Jiang3, Tao Zhao4, Rongcai Jiang5,6, 
Zhiren Zhang7, Shengjiang Tan8,9,10, Asif Ahmed11 & Yuchun Gu1,12
Serotonin or 5-hydroxytryptamine (5-HT) has been shown to be essential in lots of physiological and 
pathological processes. It is well known that 5-HT and 5-HT transporter (5-HTT) play important roles in 
the pulmonary artery in pulmonary hypertension. However, little is known about the function of 5-HTT 
in other arteries. In this study we found that the expression of 5-HTT was elevated in injured carotid 
arteries and over-expression of 5-HTT induced proliferation of smooth muscle cells (SMCs); however, 
this phenotype could be reversed by knocking-down of 5-HTT or endothelial cells conditional medium 
(EC-CM). A 5-HTT inhibitor, fluoxetine, treated animals also exhibited reduced restenosis after injury. 
We identified that miR-195 was packaged in the extracellular vesicles from EC-CM. We further confirmed 
that extracellular vesicles could transfer miR-195 from ECs to SMCs to inhibit the expression of 5-HTT 
in SMCs and the proliferation of SMCs. These results provide the first evidence that ECs communicate 
with SMCs via micro-RNA195 in the regulation of the proliferation of SMCs through 5-HTT, which will 
contribute to a better understanding of communications between ECs and SMCs via micro-RNA. Our 
findings suggest a potential target for the control of vessel restenosis.
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter and is widely present in organisms 
from nematodes to human1. 5-HT is associated with depression2, suicidal behavior and other mental disorders3. 
Apart from its function in CNS, the role of 5-HT in the cardiovascular system also attracts more and more atten-
tion. It is now well known that serotonin stimulates smooth muscle cell growth and migration4,5. 5-HT and sero-
tonin transporter (5-HTT) play a critical role in pulmonary arterial hypertension (PAH) pathogenesis. Inhibition 
of 5-HTT can prevent and reverse PAH6. Activation of 5-HT2B receptors also regulates the development of pul-
monary hypertension7. Proliferation and apoptosis of vascular smooth muscle cells (SMCs) have a critical role in 
vascular neointimal lesion formation and atherosclerosis8. Although SMCs in adults blood vessels are quiescent, 
they can be activated and become highly proliferative during vascular injury9. Several studies have shown that the 
communication between ECs and SMCs is important to regulate SMCs homeostasis10–12. However, the mecha-
nism underlying such phenomenon remains unclear.
MicroRNAs (miRNAs) are endogenous noncoding RNAs which approximately consist of 22 nucleotides. 
MicroRNAs can bind to mRNAs, which leads to the degradation or translational repression of its targeted 
mRNAs to inhibit gene expression. MicroRNAs have been proved to be messengers that can get into recipient 
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cells to regulate gene expression10,12–14. Apart from their intrinsic cellular function, the circulating microRNAs are 
enticing biomarkers and potential therapeutic targets for cardiovascular diseases15,16. ECs and SMCs play critical 
roles in vasculature homeostasis. MicroRNAs have a key role in regulating ECs function17 and SMCs turnover18. 
MicroRNA-195 has been demonstrated in association with cardiac hypertrophy, heart failure19 and diabetic car-
diomyopathy20. In this study, we addressed how miR-195 is involved in the homeostasis of vessel smooth muscle 
cells.
Results
Inhibition of Serotonin transporter (5-HTT) prevents neointima formation after balloon 
injury. 5-HTT plays a critical role in pulmonary arterial hypertension (PAH) pathogenesis. To identify the role 
of 5-HTT in injury stimulated vascular remodeling, we performed balloon angioplasty injury on rat carotid arter-
ies and examined the expression of 5-HTT. 14 days after injury, the expression of 5-HTT increased approximately 
2-fold in the injured artery compared to the contralateral uninjured carotid artery (Fig. 1a). To address whether 
5-HTT is expressed in other arteries, human coronary arteries obtained from coronary disease patients were 
analyzed by immunohistostaining. Abundant expression of 5-HTT was found in the patient’s coronary artery 
(Fig. 1b). Noticeably, the expression of 5-HTT was detected in the cultured human pulmonary smooth muscle 
cells (HPASMCs), but not in normal human coronary smooth muscle cells (HCASMCs) as revealed by RT-PCR 
(Fig. 1c). After fluoxetine, a 5-HTT inhibitor, was applied to rats to assess the potential preventive effect of 5-HTT 
suppression on neointima formation, the neointima formation was markedly attenuated in fluoxetine-treated 
Figure 1. Serotonin transporter (5-HTT) inhibition prevents neointima formation after balloon injury. 
(a) The protein level of 5-HTT in the injury and the normal carotid arteries from rat was measured by WB. 
Images are representative of triplicate experiments with similar results. Full-length blots are presented in 
Supplementary Figure 1a. **P < 0.01 compared with the sham (n = 3). (b) The expression of 5-HTT in coronary 
tissue (red) was detected by immunostaining. Nuclei were stained with DAPI (blue). Scale bar,  
2000 μ m. (c) RT-PCR was used to detect the expression of 5-HTT in human coronary artery smooth muscle 
cell (HCASMCs) and human pulmonary artery smooth muscle cell (HPASMCs). Full-length gels are presented 
in Supplementary Figure 1b. P1: primer 1, product = 162 bp; P2: primer2, product = 98 bp. (d) Representative 
images of balloon injured carotid arteries treated with vehicle or fluoxetine (n = 8). 2 weeks after the injury, 
the arteries were fixed followed with sectioning and staining with hematoxylin and eosin. Intima/media ratios 
were calculated from at least 6 rats per group. **P < 0.01 compared with sham arteries. N: neointima. Scale bar, 
2000 μ m.
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rats compared with the control group (Fig. 1d). Together, these results indicate that 5-HTT is involved in the 
neointima formation of injured artery.
Over-expression of 5-HTT promotes the proliferation of SMCs. The proliferation of SMCs is the 
major event during the neointimal formation. To determine whether 5-HTT is related to the proliferation of 
SMCs, the effects of 5-HTT on serum-stimulated cell growth of VSM were examined in human umbilical vein 
SMC freshly isolated from human umbilical cord vein. 5-HT (10 μ M) was found to promote the proliferation 
of SMCs, but this effect could be reversed by a 5-HTT inhibitor, F132 (1 μ M) (Fig. 2a). The over-expression 
and shRNA knockdown of 5-HTT were confirmed by immunoblotting (Fig. 2b). Overexpression of 5-HTT pro-
moted the proliferation of SMCs and the effect of 5HT was mildly enhanced when 5-HTT was over-expressed. 
Furthermore, knockdown of 5-HTT by shRNA inhibited the proliferation of SMCs (Fig. 2c). Taken together, 
these results suggest that 5-HTT could stimulate the proliferation of SMCs.
ECs conditional medium (EC-CM) inhibits the expression of 5-HTT in SMCs and the proliferation 
of SMCs. SMCs can be activated to be proliferative under certain pathophysiological conditions such as injury 
of ECs. We found that the communication between ECs and SMCs could regulate the expression of 5-HTT and 
the proliferation of SMCs. ECs were cultured in growth medium for 48 hours and the ECs conditional medium 
(EC-CM) was collected. SMCs were cultured in EC-CM and D/F12 medium (1:1) for 48 hours. Then the 5-HTT 
in SMC was detected by immunoblotting. We found that the expression of 5-HTT in SMCs was suppressed by 
EC-CM (Fig. 3a). EC-CM could also inhibit the proliferation of SMCs induced by the overexpression of 5-HTT 
(Fig. 3b). Furthermore, PDGF-induced upregulation of 5-HTT was also inhibited by EC-CM (Fig. 3a). Previous 
studies have shown that 5-HTT-initiated Rho kinase signaling elicited 5-HTR1B mediated phosphorylation 
of ERK by MEK. Translocation of pERK to the nucleus activated transcription factors then promoted calcium 
dependent proliferation in the PASMCs21,22. Similarly, we found elevated phosphorylation of Erk42/44 induced 
by overexpression of 5-HTT and PDGF. The elevated phosphorylation of Erk42/44 was inhibited by EC-CM 
(Fig. 3c). These results demonstrate that the communication between ECs and SMCs could regulate the expres-
sion of 5-HTT and the proliferation of SMCs.
Vesicles derived from ECs modulates the expression of 5-HTT in SMCs. As EC-CM could regulate 
the expression of 5-HTT in SMCs we speculated that EC-CM might affect the function of SMCs in a paracrine 
manner. Several recent studies indicate that vesicles can transduce signals between cells10,23,24. To study the effect 
of EC-CM on the expression of 5-HTT in SMCs, we isolated vesicles from EC-CM and identified the isolated 
Figure 2. 5-HTT promotes SMCs proliferation. (a) SMCs were treated with 5-HT or 5-HTT inhibitor F132. 
The proliferation of SMCs was determined by MTT. **P < 0.01 compared with control (n = 6). (b) Western blot 
analysis confirmed the effects of 5-HTT overexpression and shRNA knockdown on the protein levels compared 
to scrambled controls. Full-length blots are presented in Supplementary Figure 1c. **P < 0.01 compared with 
scramble controls (n = 3). (c)The proliferation level of HUVSMCs after 5-HTT overexpression and knockdown 
was measured by MTT. **P < 0.01 compared with control (n = 6).
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vesicles using electron microscopy (Fig. 4a). The diameter of the vesicles was between 30 and 100 nm, indicating 
that most of the isolated vesicles were comprised of exosomes rather than larger apoptotic bodies. The isolated 
exosome fractions were immunoreactive for the exosomal marker CD63 and CD81. In addition, CD31 was also 
detected in the isolated exosomes, indicating that the isolated exosomes were secreted by ECs. To further identify 
the function of exosomes isolated from EC-CM, we investigated the mode of alteration in EC-CM upon different 
treatments (Fig. 4b). We found that protein degradation by proteinase K or nucleotides degradation by RNase 
did not affect the function of EC-CM (Fig. 4c). In contrast, treatment with phospholipid membrane disruptors, 
Triton X-100, before RNase treatment led to a dramatic abolishment of the function of EC-CM, which indicates 
that extracellular vesicles in EC-CM were regulators of the expression of 5-HTT in SMCs.
Extracellular vesicles transfer miR195 from ECs to SMCs. We hypothesized that it was microRNAs in 
EC-CM vesicles that regulated the expression of 5-HTT. According to the prediction of TARGETSCAN (http://
www.targetscan.org/), we selected miR-15, miR-16, miR-195 and miR-322 as candidates to test their function 
associated with the expression of 5-HTT in SMC. After SMCs were transfected with miRNA mimics we found 
that miR-15, miR-16, miR-195 and miR-322 could reduce the expression of 5-HTT (Fig. 5a). Next, we checked 
the expression of miR15, miR-16, miR-195 and miR-322 in injured carotid arteries and SMCs cultured in EC-CM. 
However, only miR-15 and miR-195 showed decreased expression in the balloon injured carotid arteries (Fig. 5b). 
In the EC-CM treated SMCs, only the expression of miR-195 increased (Fig. 5c). By using the mode of different 
treatments with EC-CM (Fig. 4b), we found that treatments with proteinase K or RNase did not affect expression 
of miR-195 (Fig. 5d). In contrast, treatment with phospholipid membrane disruptors Triton X-100 followed by 
RNase treatment led to an almost complete degradation of miR-195, indicating that endothelial-derived miR-195 
was released and protected by extracellular vesicles. The expression of miRNAs in extracellular vesicles was meas-
ured by real-time quantitative PCR. The expression of miR-195 was approximately 19-fold high of the control, 
RNU6–2. The miR-15 expression was almost undetectable (Fig. 5e). To determine whether miR-195 and miR-15 
were directly delivered into SMCs, synthetic miR-15 and miR-195 mimics (oligomer labeled with FAM) were 
transfected into ECs. The culture medium was replaced after 8 hours to remove the free FAM-labeled miRNAs. 
After 24 hours the EC-CM was collected for the incubation of SMCs. We found that EC-CM derived from ECs 
transfected with the FAM-miR195 led to the presence of FAM-miR195 in SMCs, but there is no presence of 
FAM-miR15 in SMCs after incubation of EC-CM derived from ECs transfected with the FAM-miR15 (Fig. 5f). 
To further confirm the protective effect of EC vesicles, ECs were transfected with miR-195 inhibitors. Then the 
EC-CM was collected to culture SMCs. We found that the miR-195 inhibitor transfected EC-CM could not reduce 
Figure 3. ECs regulate the 5-HTT expression and proliferation of SMCs. (a) SMCs was cultured with 
EC-CM and the protein level of 5-HTT was analyzed by Western blot 48 hours later. Full-length blots are 
presented in Supplementary Figure 2a. **P < 0.01 compared with control (n = 3). (b) The proliferation level of 
SMCs after treated with EC-CM was measured by MTT. **P < 0.01 compared with control (n = 6). (c) SMCs 
were incubated with EC-CM or PDGF for 48 hours. Phosphorylation of ERK was determined by Western 
blot analysis of the whole cell lysate using the phosphor-specific antibody. Full-length blots are presented in 
Supplementary Figure 2b.
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the expression of 5-HTT in SMCs (Fig. 5g). These results suggest a direct transmission of miR-195 from ECs to 
SMCs via vesicles derived from ECs.
Discussion
5-HT and serotonin transporter (5-HTT) play important roles in the progression of pulmonary hyperten-
sion6,11,25. Although over-expression of 5-HTT promotes PAH, the functions of 5-HTT in other arteries remain 
unclear. In the present study, we demonstrated that the expression of 5-HTT was up-regulated in injured carotid 
arteries and over-expression of 5-HTT could induce proliferation of smooth muscle cells (SMCs) proliferation. 
Neointima formation is significant at two weeks and reaches it’s maximum at four weeks after balloon injury16,26. 
Similarly, we observed efficient neointima formation at two weeks after balloon injury. We also found that the 
expression of 5-HTT was up-regulated in the injured arteries. However, the neointima formation was markedly 
attenuated when the rats received fluoxetine. Although the present study only provides results from animals 
of two weeks after balloon injury, it still strongly suggests that 5-HTT plays an important role in neointima 
formation.
The excessive expression of 5-HTT accelerates the proliferation of SMCs. However, the regulation of the 
expression of 5-HTT is unknown in SMCs. Several studies have indicated that miR-15 and miR-16 regulate 
5-HTT expression in brain and placental27,28. In the present study, we found that miR15, miR-16, miR-195 and 
miR-322 could reduce the expression of 5-HTT in SMCs. However, only the expression of miR-15 and miR-195 
is decreased in the balloon injured carotid arteries. Furthermore, we found that only miR-195 in SMCs increased 
after incubation with EC-CM. These results indicate that miR-195 is a new regulator of 5-HTT in the blood 
vessels.
The elevated expression of miR-195 in SMCs after EC-CM treatment indicates that miRNAs can mediate 
signals between ECs and SMCs. Several studies have shown that the communication between cells is important 
to modulate cell function10,11,29–31. After binding to recipient cells, there are three fates of the extracellular vesicles 
(EVs): a. EVs may remain stably associated with the membrane32; b. EVs directly fuse with the membrane and 
release their contents33; c. EVs can be internalized through distinct endocytic pathways. When endocytosed, 
EVs may subsequently fuse with the endosomal delimiting membrane or be targeted to lysosomes for degrada-
tion34–36. To confirm that ECs could transfer functional miR-195 to SMCs, we transfected ECs with FAM-labeled 
miR-195 mimics. We found that ECs transfected with the FAM-miR195 led to the presence of FAM-miR195 in 
SMCs. When ECs were transfected with miR-195 inhibitors or EC-CM treated with Triton-100, EC-CM could 
not inhibit the expression of 5-HTT in SMCs. These data indicate that ECs derived vesicles can transfer miR-195 
Figure 4. EC-secreted vesicles regulate SMCs 5-HTT gene expression. (a) Left: western blot analysis of 
exosome protein. Full-length blots are presented in Supplementary Figure 2c. Right: Electron microscopy 
image of isolated extracellular vesicles of ECs (30–100 nm). (b) Schematic of the degradation assay used in 
this study. (c) EC-CM was incubated with the indicated reagents cultured SMCs. The protein of SMCs was 
extracted 48 hours later and the levels of 5-HTT was measured by WB. Full-length blots are presented in 
Supplementary Figure 3a. (d)Semi-quantification results of 5-HTT protein level after cultured with different 
treated EC-CM. **P < 0.01 compared with control (n = 3).
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from ECs into SMCs to suppress the expression 5-HTT in SMCs. MicroRNAs have crucial roles in the regulation 
of gene expression and are involved in physiological and pathological processes, such as lipid metabolism and 
Figure 5. Endothelial cells transmit miR-195 to SMCs via vesicles. (a) 5-HTT expression was inhibited after 
miR-15, miR-195, miR16, miR-322 mimics transfection in SMCs. The micro-RNA mimics were transfected into 
SMCs and the protein was extracted after 48 hours. Full-length blots are presented in Supplementary Figure 3b. 
**P < 0.01 compared with control (n = 3). (b) The miRNA level of miR-15 and miR-195 were measured by real-
time PCR in normal and injured carotid artery. **P < 0.01 compared with shame (n = 3). (c) SMCs was cultured 
by EC-CM 24 hours when RNA was isolated. The miRNA level was detected by real time PCR. **P < 0.01 
compared with control (n = 4). (d) The miRNAs expression level of extracellular vesicles from ECs was 
measured by real-time PCR (n = 3). (e) Extracellular vesicles of ECs were incubated with the indicated reagents 
before isolating RNA and measuring the levels of the indicated miRNAs by real-time PCR. **P < 0.01 compared 
with control (n = 4). (f) SMCs were treated with EC-CM from FAM-linked miRNA transfected ECs. FAM-
linked miRNA in ECs and SMCs was detected by fluorescence microscopy. (g) ECs were transfected with miR-
195 inhibitors and the EC-CM were used to culture SMCs. The protein of SMCs was extracted 48 hours later and 
the levels of 5-HTT was measured by WB. Full-length blots are presented in Supplementary Figure 3c.
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atherosclerosis. Variation in the expression of one miRNA can affect various steps of one signaling pathway37. 
Therefore miRNAs can be exploited as future diagnostic and even therapeutic targets. In the present study, we 
found that a new extracellular messenger derived from ECs, miR-195 could regulate the expression of 5-HTT in 
SMCs and the proliferation of SMCs. Thus miR-195/5-HTT may act as a promising therapeutic target for vascular 
restenosis in the future. Further investigation of the regulation of miR-195 in ECs will be eminent to evaluate its 
role in pathological processes, such as vessel restenosis. Further study is also needed to assess the protective effect 
of ECs on neointima formation, especially the effect of ECs from miR-195 knockout mice.
In summary, our data show that the overexpression of 5-HTT promotes the proliferation of SMCs and inhibi-
tion of 5-HTT prevents neointima formation in rat’s carotid artery. ECs derived miR-195 acts as a new regulator 
to modulate the expression of 5-HTT in SMCs. These findings confirm that ECs play an important role in the 
prevention of SMC from over-proliferation, which provides a new underlying mechanism responsible for the 
occurrence and development of restenosis.
Material and Methods
Cell culture and transfection. Human coronary and pulmonary smooth muscle cells (HCASMCs and 
HPASMCs) were purchased from Promo Cell. Human umbilical vein endothelial cells (HUVEC) and human 
umbilical vein smooth muscle cells (HUVSMCs) were freshly isolated from human umbilical cord vein as pre-
viously described38,39 and cultured with ECs growth medium (Promo Cell) and DMEM/F12 supplemented with 
10% FCS, 1% sodium pyruvate, 1% glutamine and 1% penicillin and streptomycin respectively. The protocols for 
human umbilical cord collection and isolation of human umbilical vein endothelial cells (HUVECs) and human 
umbilical vein smooth muscle cells (HUVSMCs) were approved by University Ethics Committee, Institute of 
Molecular Medicine, Peking University. All methods for human tissues were performed in accordance with the 
relevant guidelines and regulations. The informed consent was obtained from all subjects.
The short hairpin RNA (shRNA) used in this study was obtained from Zhang laboratory, School of Life 
Sciences, Peking University, Beijing, China. NON-TARGET shRNA Control Vector was used as negative con-
trol in the 5-HTT knockdown experiment. The plasmid of 5-HTT over-expression was purchased from Vigene 
bioscience (Shandong, China). MicroRNA mimics and inhibitors were purchased from GenePharma (Shanghai, 
China). The plasmid, mircoRNA mimics and inhibitors were introduced into ECs and SMCs using Lipofectamine 
2000 (Invitrogen) according to the manufacturer’s instructions.
Animals. All experimental protocols were approved by University Ethics Committee, Institute of Molecular 
Medicine, Peking University. All animals received humane care in compliance Guide for the Institutional Animal 
Care and Use Committee (IACUC).
Adult male Sprague Dawley rats (300 g) were purchased from Vital River (Beijing, China). All surgeries 
were performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering. Male 
Sprague-Dawley rats weighing 350–400 g were used in the balloon injury model. The rats were anesthetized via 
intraperitoneal injection with 2% sodium pentobarbital (Sigma). The rats were injected with 100U/kg heparini-
zation before balloon injury. The left carotid arteries of the animals were isolated, and the balloon was introduced 
into the left common carotid through the left external carotid artery. The balloon was inflated to produce moder-
ate resistance to catheter movement and then was withdrawn gradually to the near entry point. The entire proce-
dure was repeated three times. Rats in sham group underwent the same procedure, except for artery injury. After 
the surgery, the rats were injected with penicillin (200,000 U) to prevent infections. Then, to assess the potential 
preventive effect of 5-HTT inhibition on neointima formation, the rats were assigned into two groups randomly 
(8 animals in each group): one group received fluoxetine at 10 mg/kg/day and one group received vehicle only. 
All animals were fed with conventional diet until sacrificed. Euthanasia was achieved by isoflurane inhalational 
anesthesia (1.5%) and concurrent an aesthetic overdose as approved by the respective University IACUCs.
RNA preparation, RT-PCR and Real-time PCR analysis. Total RNA was isolated using TRIZOL 
(Invitrogen). Total RNA was reverse transcribed into cDNA using EasyScript First-Strand cDNA Synthesis 
SuperMix kit (TransGen Biotech). The cDNA used in real time PCR was synthesized by miRNA cDNA synthe-
sis kit (CWBIO). The miRNA expression level was analyzed by Fast 7500 thermocycler (Applied Biosytems). 
RNU6-2 was used as a normalization control in all miRNA measurements. Primers used in this study are listed 
below.
5-HTT Primer 1:
F: 5-AGAATTTTACACGCGCCACG-3′ ; R:5′ -GAGGTCTTGACGCCTTTCCA-3′ 
5-HTT Primer 2:
F:5- CCTCATTGCCACCTTCCTGT-3′ ; R: 5- CAGCCAAGCCATGGTGACTA-3′ 
18S Primer:
F: 5′ -CAGCCACCCGAGATTGAGCA-3′ ; R:5′ -TAGTAGCGACGGGCGGTGT-3′ 
RNU6-2 Primer:
F: 5′ - CTCGCTTCGGCAGCACA -3′ ; R:5′ - AACGCTTCACGAATTTGCGT -3′ 
Immunoblotting. The protein samples obtained from tissue or cell extracts were quantified using the 
Bradford reagent (BioRad). Before loading into the 10% SDS-PAGE, the samples were mixed with 5x loading 
buffer and boiled at 98 °C for 5 mins. After gel electrophoresis, the proteins were then transferred to a PVDF 
membrane (0.45 μ m, Merck Millipore) under 250 mA for 90 mins. The membranes were incubated with a block-
ing buffer (5% nonfat milk in Tris-buffered saline containing 0.5% Tween-20) for 1hr at room temperature and 
then incubated with the indicated primary antibodies at 4 °C overnight. The membrane was incubated with 
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horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G (IgG; 1:5000) or with goat anti-rabbit 
IgG (1:5000) for one hour at room temperature. The target protein bands were visualized using Amersham Imager 
600 (GE healthcare). The following antibodies were used: goat Anti-Serotonin transporter (Abcam, #ab130130), 
rabbit anti-p44/42 MAPK (Cell Signaling, #4695 s), rabbit anti-Phospho-p44/42 MAPK (Cell Signaling, #4370 s), 
mouse anti-ß-actin (Beijing TDY Biotech LTD, #M009), HRP-conjugated secondary mouse (Beijing TDY Biotech 
LTD, #E009) goat (Beijing TDY Biotech LTD, S008) and rabbit antibodies (Beijing TDY Biotech LTD, #E011).
Cell proliferation assay. 3,000 smooth muscle cells were seeded in each well of 96-well plate. The VSMCs 
were treated with DMEM/F12 including 0.5% FBS for 12 hours before the assay. After different treatments, 20 ul 
of MTT was added to each well for 3 h incubation. Subsequently, cells were dissolved by 150 mL of DMSO, mixed 
and measured the absorbance by Multiskan (Thermo) at 540 nm. The relative proliferation rate was calculated by 
the absorbance ratio of the drug-treated group to the control group.
Extracellular vesicles isolation. Exosomes were isolated from conditioned medium (CM) using a 
multi-step centrifugation procedure as described previously40. Briefly, ECs were cultured with EC growth 
medium with exosome-free serum (Promo Cell). After cultivation for 72 h, the supernatant was collected centri-
fuge at 300 g for 10 min at 4 °C to pellet the cells. To remove cells and cell debris, the supernatant was centrifuged 
at 16,500 g for 20 min at 4 °C. Then filter the supernatant through a 0.2 μ m filter to remove particles larger than 
200 nm. The filtered supernatant was centrifuged at 120,00 g for 70 min at 4 °C to pellet the exosomes. The super-
natant was discarded and the pelleted vesicles were re-suspended in a small volume of an appropriate buffer. 500 μ l 
TRIZOL (Invitrogen) for RNA isolation or in PBS for electron microscopy.
Electron microscopy. Exosomes were collected from EC-CM as described above, pelleted for preparation 
of the carbon coated copper grid (Beijing Zhongjingkeyi Technology). The grids with exosomes were negatively 
stained with 2% phosphotungstic acid (PTA), and imaged with transmission electron microscope.
Histological analysis. The human coronary disease artery was obtained from Fuwai Hospital in Beijing, 
China. The collection of human artery tissue were performed in agreement with the guidelines approved by the 
Institutional Review Board at FuWai Hospital. All experimental protocols were approved by University Ethics 
Committee, Institute of Molecular Medicine, Peking University. All methods were performed in accordance with 
the relevant guidelines and regulations. Informed consents were obtained from all subjects. The artery was fixed in 
4% paraformaldehyde and embedded in paraffin. For 5-HTT immunohistochemical staining, paraffin-embedded 
tissue sections were deparaffinized and rehydrated, and then autoclaved in 10 mmol/L citrate buffer for antigen 
retrieval. After quenching endogenous peroxidase, the sections were incubated with goat Anti-Serotonin trans-
porter (Abcam, #ab130130) at 4 °C overnight. The sections were incubated with horseradish Cy3-conjugated goat 
anti-mouse IgG (IgG; 1:5000) for one hour at room temperature.
In the rat experiment, the left and right common arteries were isolated and fixed in 4% paraformaldehyde at 
the 14th day after operation. After embedded in paraffin, arteries were cut into sections of 4 μ m thickness and 
stained with hematoxylin and eosin. The sections were viewed with an Eclipse 600 Nikon microscope and photo-
graphed with a digital camera.
Statistical analysis. All statistical analyses were carried out using Graphpad Prism 6. Data are expressed 
as average ± SEM of at least three independent experiments. The statistical significance was determined using a 
t-test when comparing two groups and ANOVA when comparing multiple groups. A value of P < 0.05 was con-
sidered statistically significant.
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